PIRON 267

Šalis: Izraelis

kalba: anglų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

PIRFENIDONE

Prieinama:

UNIPHARM LTD, ISRAEL

ATC kodas:

L04AX05

Vaisto forma:

TABLETS

Sudėtis:

PIRFENIDONE 267 MG

Vartojimo būdas:

PER OS

Recepto tipas:

Required

Pagaminta:

UNIPHARM LTD, ISRAEL

Gydymo sritis:

PIRFENIDONE

Terapinės indikacijos:

Piron is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF)

Leidimo data:

2023-10-17

Pakuotės lapelis

1
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986
The medicine is dispensed with a doctor’s prescription only
PIRON 801
FILM-COATED TABLETS
Composition:
EACH TABLET CONTAINS:
pirfenidone 801 mg
PIRON 267
FILM-COATED TABLETS
EACH TABLET CONTAINS:
pirfenidone 267 mg
FOR THE LIST OF INACTIVE INGREDIENTS AND ALLERGENS IN THIS MEDICINE:
see section 2
under ‘Important information about some of this medicine’s
ingredients’, and
section
6
‘
Additional information
’
.
READ THIS LEAFLET IN ITS ENTIRETY BEFORE USING THE MEDICINE.
This leaflet contains
concise information about this medicine. If you have any further
questions, consult
your doctor or pharmacist. Keep this leaflet; you may need to read it
again.
This medicine has been prescribed to treat your illness. Do not pass
it on to others. It
may harm them, even if it seems to you that their ailment is similar.
1.
WHAT IS THIS MEDICINE INTENDED FOR?
PIRON
contains the active ingredient _pirfenidone_ and is used for the
treatment of mild
to moderate Idiopathic Pulmonary Fibrosis (IPF) in adults.
Therapeutic group:
PIRON
is an immunosuppressant.
Idiopathic pulmonary fibrosis is a condition in which the lung tissues
become swollen
and scarred over time and as a result, it is difficult to breathe
deeply. This makes it
hard for the lungs to function properly.
PIRON
helps to reduce scarring and swelling in
the lungs, and helps you breathe better.
2.
BEFORE USING THIS MEDICINE
Do not use the medicine if:
•
you are sensitive (allergic) to the active ingredient pirfenidone or
to any of the
other ingredients in this medicine which are mentioned in section 2
under
‘Important information about some of this medicine’s
ingredients’, and section 6
‘Additional information’.
•
you have previously experienced angioedema with pirfenidone, including
symptoms such as swelling of the face, lips and/or tongue which may be
associated with breathing difficulties or wheezing.
•
you are taking a medicine called fluvoxamine